CVS Health's Merlo touts Aetna integration, opening of concept storeSix weeks after closing its merger with Aetna, CVS Health president and CEO Larry Merlo outlined new initiatives. Cardinal Health Foundation provides grant for Ohio opioid initiativeThe Cardinal Health Foundation is providing a $530,000 grant to fight opioid misuse and abuse. Amgen cuts prices for Repatha devices Amgen’s Repatha device options, including its prefilled syringe, are being offered at a 60% reduced price of $5,850 per year. MinuteClinic debuts in Dallas, Pennsylvania MinuteClinic has added a location inside a Dallas, Pa., CVS Pharmacy store. FDA approves Lupin's generic Latuda Lupin has received the FDA's approval for generic Latuda tablets, which had a market value of roughly $3.2 billion. Diplomat adjusts guidance amid exec shake-ups Diplomat announced changes to its executive team and revised its guidance for its 2018 fiscal year. Ritzman sells Rx business to CVS Pharmacy CVS Pharmacy is set to acquire 20 of Ritzman Pharmacy's retail pharmacies by the end of February. Pliaglis’ ‘Not for Home Use’ label restriction gets green lighted Crescita's Pliaglis received approval from the Food and Drug Administration for removal of the "Not for Home Use" label restriction. Patient-facing pharmacies: Technology for enhanced engagement LexisNexis Risk Solutions' Craig Ford looks at how pharmacists play a key role in care delivery as patients can walk right up to the counter with a question without an appointment. Hy-Vee implements controlled substance prescription policy Hy-Vee's pharmacies are aiming to combat the opioid epidemic with a new controlled substance prescription policy. First Previous 562 563 564 565 566 Next Last
